Dynamic Technology Lab’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Dynamic Technology Lab’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,280	Closed	-$259K	–	1633
2022 Q3	$259K	Buy	+10,280	New	+$285K	0.03%	868
2022 Q1	–	Sell	-15,700	Closed	-$414K	–	1635
2021 Q4	$414K	Buy	15,700 +13,390	+580%	+$1.04M	0.05%	675
2021 Q3	$233K	Buy	+2,310	New	+$271K	0.03%	852
2021 Q2	–	Sell	-5,713	Closed	-$570K	–	1654
2021 Q1	$570K	Buy	+5,713	New	+$666K	0.06%	501
2020 Q3	–	Sell	-1,619	Closed	-$253K	–	1429
2020 Q2	$253K	Buy	+1,619	New	+$246K	0.04%	736
2020 Q1	–	Sell	-1,722	Closed	-$352K	–	1455
2019 Q4	$352K	Sell	1,722 -1,278	-43%	-$233K	0.06%	602
2019 Q3	$241K	Buy	+3,000	New	+$255K	0.04%	753
2019 Q2	–	Sell	-3,531	Closed	-$302K	–	1374
2019 Q1	$302K	Buy	+3,531	New	+$293K	0.05%	657
2017 Q1	–	Sell	-9,908	Closed	-$216K	–	1336
2016 Q4	$216K	Buy	+9,908	New	+$251K	0.06%	694

Other funds holding RETA

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Dynamic Technology Lab's RETA Position: Q4 2022 in Review

Dynamic Technology Lab sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2022, closing a stake of 10,280 shares — an estimated $259K sold.

Dynamic Technology Lab first reported a position in RETA in Q4 2016 and held it in 9 quarters. The position peaked at $570K in Q1 2021. 168 funds tracked by Wall St. Rank hold RETA as of Q4 2022.

Dynamic Technology Lab reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Dynamic Technology Lab sold 10,280 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2022, an estimated $259K.
Dynamic Technology Lab first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2016 and held it in 9 quarters.
Dynamic Technology Lab's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $570K in Q1 2021.
168 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2022.

Based on Dynamic Technology Lab's 13F filing for Q4 2022, filed 14 Feb 2023.